Patents-Review.com
🔗 Permalink
Assignee profile:

Actelion Pharmaceuticals Ltd.

City:

Allschwil

Country:

Switzerland

Published Applications:

225

Last publication date:

2023-04-27

Patent Grants:

200

Last grant date:

2025-06-24

Quarterly Actelion Pharmaceuticals Ltd. Patent Applications

Top Inventors for applications by Actelion Pharmaceuticals Ltd.

These are the the leading inventors for applications assigned to Actelion Pharmaceuticals Ltd.:

Recent patent applications by Actelion Pharmaceuticals Ltd.

Actelion Pharmaceuticals Ltd. based in Allschwil, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-04-27 ✅ Patent 12,336,980 granted on 2025-06-24
US20230131600A1
Human necessities

DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST

 #2 | 2023-02-02 ✅ Patent 12,485,119 granted on 2025-12-02
US20230032813A1
Human necessities

METHODS OF TREATING PULMONARY ARTERIAL HYPERTENSION

 #3 | 2022-10-20 ✅ Patent 11,612,600 granted on 2023-03-28
US20220331319A1
Human necessities

Pharmaceutical composition comprising macitentan for the treatment of chronic thromboembolic pulmonary hypertension

 #4 | 2022-08-18 ✅ Patent 12,419,887 granted on 2025-09-23
US20220257594A1
Human necessities

TRANSITIONING PATIENTS TREATED FOR PULMONARY ARTERIAL HYPERTENSION TO SELEXIPAG

 #5 | 2022-03-31 ✅ Patent 11,464,777 granted on 2022-10-11
US20220096476A1
Human necessities

Pharmaceutical composition for the treatment of pulmonary arterial hypertension

 #6 | 2021-12-30
US20210401811A1
Human necessities

DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST

 #7 | 2021-11-04 ✅ Patent 11,672,783 granted on 2023-06-13
US20210338640A1
Human necessities

Pharmaceutical combination comprising a selective S1P1 receptor agonist

 #8 | 2021-07-01 ✅ Patent 11,234,980 granted on 2022-02-01
US20210196715A1
Human necessities

Pharmaceutical composition for the treatment of pulmonary arterial hypertension

 #9 | 2021-06-24 ✅ Patent 11,648,249 granted on 2023-05-16
US20210186966A1
Human necessities

Stable pharmaceutical compositions comprising a pyrimidine-sulfamide

 #10 | 2021-02-25 ✅ Patent 11,771,683 granted on 2023-10-03
US20210052555A1
Human necessities

Dosing regimen for a selective S1Preceptor agonist

 #11 | 2020-05-28 ✅ Patent 11,136,317 granted on 2021-10-05
US20200165235A1
Chemistry; metallurgy

NADPH oxidase 4 inhibitors

 #12 | 2020-04-30 ✅ Patent 12,121,516 granted on 2024-10-22
US20200129506A1
Human necessities

Pharmaceutical composition comprising selexipag

 #13 | 2020-03-05 ✅ Patent 11,723,896 granted on 2023-08-15
US20200069655A1
Human necessities

Pharmaceutical combination comprising ponesimod

 #14 | 2019-06-13 ✅ Patent 11,026,927 granted on 2021-06-08
US20190175563A1
Human necessities

Pharmaceutical combination comprising a selective S1P1 receptor agonist

 #15 | 2019-05-23 ✅ Patent 10,857,134 granted on 2020-12-08
US20190151292A1
Human necessities

Dosing regimen for a selective S1Preceptor agonist

 #16 | 2018-09-20 ✅ Patent 10,946,015 granted on 2021-03-16
US20180263980A1
Human necessities

Stable pharmaceutical compositions comprising a pyrimidine-sulfamide

 #17 | 2018-08-16 ✅ Patent 10,246,426 granted on 2019-04-02
US20180230109A1
Chemistry; metallurgy

Triazole compounds as T-type calcium channel blockers

 #18 | 2018-06-28 ✅ Patent 10,584,118 granted on 2020-03-10
US20180179194A1
Chemistry; metallurgy

NADPH oxidase 4 inhibitors

 #19 | 2018-06-07
US20180155344A1
Chemistry; metallurgy

TRICYCLIC PIPERIDINE COMPOUNDS

 #20 | 2018-05-31 ✅ Patent 10,220,023 granted on 2019-03-05
US20180147188A9
Human necessities

Dosing regimen for a selective S1Preceptor agonist

 #21 | 2018-01-04 ✅ Patent 10,023,560 granted on 2018-07-17
US20180002317A1
Chemistry; metallurgy

Crystalline salt form of (S)-(2-(6 chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone as orexin receptor antagonist

 #22 | 2017-12-07 ✅ Patent 10,245,253 granted on 2019-04-02
US20170348287A1
Human necessities

Pharmaceutical combination comprising a selective S1P1 receptor agonist

 #23 | 2017-11-09 ✅ Patent 10,220,023 granted on 2019-03-05
US20170319555A1
Human necessities

Dosing regimen for a selective S1Preceptor agonist

 #24 | 2017-05-11 ✅ Patent 9,850,241 granted on 2017-12-26
US20170129884A1
Chemistry; metallurgy

Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators

 #25 | 2017-04-20 ✅ Patent 9,951,063 granted on 2018-04-24
US20170107214A1
Chemistry; metallurgy

8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivatives

 #26 | 2017-02-02 ✅ Patent 9,624,206 granted on 2017-04-18
US20170029411A1
Chemistry; metallurgy

Antibacterial 1-indazole and 1-indole derivatives

 #27 | 2016-11-03 ✅ Patent 9,676,731 granted on 2017-06-13
US20160318879A1
Chemistry; metallurgy

Preparation of pyrimidine intermediates useful for the manufacture of macitentan

 #28 | 2016-10-06 ✅ Patent 10,189,839 granted on 2019-01-29
US20160289232A1
Chemistry; metallurgy

Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase

 #29 | 2016-10-06 ✅ Patent 9,676,761 granted on 2017-06-13
US20160289221A1
Chemistry; metallurgy

Difluoroethyl-oxazole substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists

 #30 | 2016-09-22 ✅ Patent 9,765,092 granted on 2017-09-19
US20160272655A1
Chemistry; metallurgy

Tricyclic piperidine compounds

 #31 | 2016-07-14 ✅ Patent 9,663,473 granted on 2017-05-30
US20160200686A1
Chemistry; metallurgy

Benzimidazolyl-methyl urea derivatives as ALX receptor agonists

 #32 | 2016-06-02 ✅ Patent 9,533,964 granted on 2017-01-03
US20160152584A1
Chemistry; metallurgy

Piperazine substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists

 #33 | 2016-05-26 ✅ Patent 9,556,125 granted on 2017-01-31
US20160145215A1
Chemistry; metallurgy

Process for preparing a pyrimidine intermediate

 #34 | 2016-05-19 ✅ Patent 10,117,870 granted on 2018-11-06
US20160136163A1
Human necessities

Stable pharmaceutical compositions comprising a pyrimidine-sulfamide

 #35 | 2016-05-05 ✅ Patent 10,603,428 granted on 2020-03-31
US20160121043A1
Human necessities

Device for dispensing a fluid to a patient

 #36 | 2016-03-17 ✅ Patent 9,527,867 granted on 2016-12-27
US20160075722A1
Chemistry; metallurgy

Antibacterial biaromatic derivatives

 #37 | 2016-03-03 ✅ Patent 9,540,399 granted on 2017-01-10
US20160060276A1
Chemistry; metallurgy

Quinolone derivatives

 #38 | 2016-02-25 ✅ Patent 9,422,249 granted on 2016-08-23
US20160052891A1
Chemistry; metallurgy

Preparation of pyrimidine intermediates useful for the manufacture of macitentan

 #39 | 2016-02-04 ✅ Patent 9,617,250 granted on 2017-04-11
US20160031866A1
Chemistry; metallurgy

Pyridin-4-yl derivatives

 #40 | 2016-01-28 ✅ Patent 9,403,813 granted on 2016-08-02
US20160024064A1
Chemistry; metallurgy

Azetidine amide derivatives as orexin receptor antagonists

 #41 | 2016-01-28 ✅ Patent 9,637,473 granted on 2017-05-02
US20160024050A1
Chemistry; metallurgy

Acrylamide derivatives as antimalarial agents

 #42 | 2016-01-28 ✅ Patent 9,597,331 granted on 2017-03-21
US20160022678A1
Human necessities

Therapeutic compositions containing macitentan

 #43 | 2015-12-17 ✅ Patent 9,388,198 granted on 2016-07-12
US20150361097A1
Chemistry; metallurgy

Heterocyclic amide derivatives as P2Xreceptor antagonists

 #44 | 2015-12-17 ✅ Patent 9,388,197 granted on 2016-07-12
US20150361096A1
Chemistry; metallurgy

Heterocyclic amide derivatives as P2X7 receptor antagonists

 #45 | 2015-12-10 ✅ Patent 9,487,516 granted on 2016-11-08
US20150353547A1
Chemistry; metallurgy

Antibacterial oxadiazolone derivatives

 #46 | 2015-12-03 ✅ Patent 9,556,117 granted on 2017-01-31
US20150344425A1
Chemistry; metallurgy

Indole carboxamide derivatives as P2Xreceptor antagonists

 #47 | 2015-11-26 ✅ Patent 9,428,456 granted on 2016-08-30
US20150336893A1
Chemistry; metallurgy

1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives

 #48 | 2015-11-12 ✅ Patent 9,718,774 granted on 2017-08-01
US20150322008A1
Chemistry; metallurgy

Indole carboxamide derivatives as P2X7 receptor antagonist

 #49 | 2015-09-24 ✅ Patent 10,251,867 granted on 2019-04-09
US20150265580A1
Human necessities

Dosing regimen for a selective S1Preceptor agonist

 #50 | 2015-09-10 ✅ Patent 9,255,090 granted on 2016-02-09
US20150252036A1
Chemistry; metallurgy

Heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators

 #51 | 2015-09-10 ✅ Patent 9,493,446 granted on 2016-11-15
US20150252032A1
Chemistry; metallurgy

Orexin receptor antagonists which are [bi-(hetero-)aryl]-[2-(bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives

 #52 | 2015-09-03 ✅ Patent 9,211,279 granted on 2015-12-15
US20150246021A1
Human necessities

Proline sulfonamide derivatives as orexin receptor antagonists

 #53 | 2015-07-23 ✅ Patent 9,340,518 granted on 2016-05-17
US20150203459A1
Chemistry; metallurgy

Process for the preparation of (2Z,5Z)-5-(3-chloro-4-(()-2,3-dihydroxypropdxy)benzylidene)-2-(propylimino)-3-(-tolyl)thiazolidin-4-one and intermediate used in said process

 #54 | 2015-06-18 ✅ Patent 9,732,075 granted on 2017-08-15
US20150166527A1
Chemistry; metallurgy

Benzimidazole-proline derivatives

 #55 | 2015-06-11 ✅ Patent 9,169,270 granted on 2015-10-27
US20150158883A1
Chemistry; metallurgy

1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators

 #56 | 2015-06-11 ✅ Patent 9,150,566 granted on 2015-10-06
US20150158855A1
Chemistry; metallurgy

2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonists

 #57 | 2015-05-21 ✅ Patent 9,284,288 granted on 2016-03-15
US20150141482A1
Chemistry; metallurgy

1-(p-tolyl) cyclopropyl substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists

 #58 | 2015-05-14
US20150133669A1
Chemistry; metallurgy

NEW PROCESS FOR THE PREPARATION OF 2-CYCLOPENTYL-6-METHOXY-ISONICOTINIC ACID

 #59 | 2015-04-30 ✅ Patent 9,139,524 granted on 2015-09-22
US20150118258A1
Chemistry; metallurgy

Fluorinated bridged spiro[2.4]heptane derivatives as ALX receptor agonists

 #60 | 2015-03-26 ✅ Patent 9,187,476 granted on 2015-11-17
US20150087840A1
Chemistry; metallurgy

Process for manufacturing naphthyridine derivatives

 #61 | 2015-02-26 ✅ Patent 9,000,029 granted on 2015-04-07
US20150057328A1
Chemistry; metallurgy

Proline sulfonamide derivatives as orexin receptor antagonists

 #62 | 2015-02-19 ✅ Patent 9,079,922 granted on 2015-07-14
US20150051188A1
Chemistry; metallurgy

2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

 #63 | 2015-01-22 ✅ Patent 9,127,002 granted on 2015-09-08
US20150025244A1
Chemistry; metallurgy

Process for manufacturing a naphthyridine derivative

 #64 | 2015-01-22 ✅ Patent 9,409,917 granted on 2016-08-09
US20150025075A1
Chemistry; metallurgy

Heterocyclic amide derivatives as P2X7 receptor antagonists

 #65 | 2014-12-18 ✅ Patent 9,266,876 granted on 2016-02-23
US20140371204A1
Chemistry; metallurgy

4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives

 #66 | 2014-11-06 ✅ Patent 9,173,881 granted on 2015-11-03
US20140329824A1
Human necessities

Therapeutic compositions containing macitentan

 #67 | 2014-10-23 ✅ Patent 10,660,880 granted on 2020-05-26
US20140316140A1
Human necessities

Dosing regimen for a selective S1Pagonist

 #68 | 2014-10-16 ✅ Patent 9,029,368 granted on 2015-05-12
US20140309218A1
Chemistry; metallurgy

3,7-disubstituted octahydro-2H-pyrido[4,3-E][1,3]oxazin-2-one antibiotics

 #69 | 2014-10-09 ✅ Patent 9,199,935 granted on 2015-12-01
US20140303208A1
Chemistry; metallurgy

Pharmaceutically active piperidine derivatives

 #70 | 2014-07-10 ✅ Patent 9,382,191 granted on 2016-07-05
US20140194526A1
Human necessities

Stabilized compositions of volatile alkylating agents and methods of using thereof

 #71 | 2014-07-03
US20140187810A1
Chemistry; metallurgy

STABILIZED COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF USING SAME

 #72 | 2014-06-19 ✅ Patent 8,916,573 granted on 2014-12-23
US20140171425A1
Chemistry; metallurgy

Quinazoline-2,4-dione derivatives

 #73 | 2014-06-12 ✅ Patent 9,221,832 granted on 2015-12-29
US20140163035A1
Chemistry; metallurgy

Heterocyclic amide derivatives as P2X7 receptor antagonists

 #74 | 2014-05-29
US20140148460A1
Human necessities

THERAPEUTIC COMPOSITIONS

 #75 | 2014-05-22 ✅ Patent 9,346,804 granted on 2016-05-24
US20140142093A1
Chemistry; metallurgy

Tricyclic oxazolidinone antibiotic compounds

 #76 | 2014-03-13
US20140073651A1
Chemistry; metallurgy

BENZAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS

 #77 | 2014-02-13 ✅ Patent 9,096,595 granted on 2015-08-04
US20140045870A1
Chemistry; metallurgy

7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators

 #78 | 2014-02-06 ✅ Patent 8,889,676 granted on 2014-11-18
US20140038961A1
Chemistry; metallurgy

3-ureidoisoquinolin-8-yl derivatives

 #79 | 2013-12-26
US20130345199A1
Chemistry; metallurgy

1-[M-CARBOXAMIDO(HETERO)ARYL-METHYL]-PIPERIDINE-4-CARBOXAMIDE DERIVATIVES

 #80 | 2013-12-05 ✅ Patent 9,303,023 granted on 2016-04-05
US20130324579A1
Chemistry; metallurgy

Pyrazole and imidazole derivatives useful as orexin antagonists

 #81 | 2013-11-28
US20130317048A1
Human necessities

COMBINATION COMPRISING PACLITAXEL FOR TREATING OVARIAN CANCER

 #82 | 2013-11-21 ✅ Patent 8,664,278 granted on 2014-03-04
US20130310461A1
Human necessities

Stabilized compositions of volatile alkylating agents and methods of using thereof

 #83 | 2013-11-21 ✅ Patent 9,000,018 granted on 2015-04-07
US20130310432A1
Chemistry; metallurgy

Thiazolidin-4-one-derivatives

 #84 | 2013-11-21
US20130310407A1
Human necessities

COMBINATIONS COMPRISING MACITENTAN FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

 #85 | 2013-11-14 ✅ Patent 9,133,179 granted on 2015-09-15
US20130303514A1
Chemistry; metallurgy

2-methoxy-pyridin-4-yl-derivatives

 #86 | 2013-10-31 ✅ Patent 8,816,118 granted on 2014-08-26
US20130289295A1
Chemistry; metallurgy

Diastereoselective preparation of bicyclo[2.2.2]octan-2-one compounds

 #87 | 2013-10-24 ✅ Patent 8,664,203 granted on 2014-03-04
US20130281406A2
Chemistry; metallurgy

Thiazole derivatives and their use as P2Y12 receptor antagonists

 #88 | 2013-10-10 ✅ Patent 9,346,793 granted on 2016-05-24
US20130267569A1
Chemistry; metallurgy

Hydroxylated aminotriazole derivatives as ALX receptor agonists

 #89 | 2013-10-03 ✅ Patent 8,846,733 granted on 2014-09-30
US20130261159A1
Chemistry; metallurgy

Oxazolyl-methylether derivatives as ALX receptor agonists

 #90 | 2013-09-12 ✅ Patent 9,242,970 granted on 2016-01-26
US20130237525A1
Chemistry; metallurgy

Lactam derivatives useful as orexin receptor antagonists

 #91 | 2013-09-05 ✅ Patent 9,187,435 granted on 2015-11-17
US20130231319A1
Chemistry; metallurgy

Bridged Spiro[2.4]heptane ester derivatives

 #92 | 2013-08-15 ✅ Patent 9,296,673 granted on 2016-03-29
US20130211104A1
Chemistry; metallurgy

Preparation of bicyclo[2.2.2]octan-2-one compounds

 #93 | 2013-08-15
US20130210830A9
Human necessities

THERAPEUTIC COMPOSITIONS

 #94 | 2013-08-01 ✅ Patent 9,057,726 granted on 2015-06-16
US20130196348A1
Physics

Neuropeptide Q as modulator of GPCR GALR2 and uses thereof

 #95 | 2013-07-25 ✅ Patent 9,265,762 granted on 2016-02-23
US20130190336A1
Human necessities

Stable pharmaceutical compositions comprising a pyrimidine-sulfamide

 #96 | 2013-06-13 ✅ Patent 8,895,606 granted on 2014-11-25
US20130150424A1
Chemistry; metallurgy

Proline sulfonamide derivatives as orexin receptor antagonists

 #97 | 2013-05-02 ✅ Patent 8,575,158 granted on 2013-11-05
US20130109685A1
Chemistry; metallurgy

1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin Dreceptor modulators

 #98 | 2013-03-14 ✅ Patent 8,697,869 granted on 2014-04-15
US20130065902A1
Chemistry; metallurgy

3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators

 #99 | 2013-01-17 ✅ Patent 8,598,227 granted on 2013-12-03
US20130018093A1
Human necessities

Epoprostenol formulation and method of making thereof

 #100 | 2013-01-03
US20130005734A1
Human necessities

THERAPEUTIC COMPOSITIONS

Also check out Actelion Pharmaceuticals Ltd's (Allschwil, Switzerland) applicant profile with 67 patent applications submitted.

AssigneeID:

1943 ⎘